Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine...

Area of Science:

• Cardiology
• Vascular Surgery
• Anesthesiology

Background:

• Major vascular surgery poses a high risk for perioperative cardiac complications.
• Dobutamine stress echocardiography (DSE) and clinical factors can identify high-risk patients, but noninvasive imaging has drawbacks.
• Perioperative beta-blocker therapy has shown promise in reducing complications in high-risk surgical patients.

Purpose of the Study:

• To investigate the interplay between clinical characteristics, DSE findings, beta-blocker use, and cardiac events in patients undergoing major vascular surgery.
• To determine the prognostic value of DSE in different risk strata of patients undergoing major vascular surgery.
• To evaluate the impact of beta-blocker therapy on perioperative cardiac outcomes.

Main Methods:

• A multi-center cohort study involving 1351 consecutive patients undergoing major vascular surgery between 1996 and 1999.
• Dobutamine stress echocardiography (DSE) was performed in 81% of patients, and 27% received beta-blocker therapy.
• The primary outcome was 30-day perioperative cardiac death or nonfatal myocardial infarction, analyzed in relation to clinical factors, DSE results, and beta-blocker use.

Main Results:

• The overall incidence of perioperative cardiac death or myocardial infarction was 3.3% (45 patients).
• Age, angina, prior myocardial infarction, heart failure, and cerebrovascular accident were significant clinical predictors of adverse outcomes.
• In clinically low-risk patients (<3 risk factors), beta-blocker therapy was associated with a lower complication rate (0.8% vs. 2.3%), and DSE added minimal prognostic value.
• In intermediate- to high-risk patients (≥3 risk factors), DSE provided additional prognostic information, differentiating risk based on stress-induced ischemia.

Conclusions:

• Dobutamine stress echocardiography (DSE) has limited additional predictive value in clinically low-risk patients who are already receiving beta-blockers.
• DSE may be safely omitted in a significant number of low-risk patients, allowing for prompt surgical intervention.
• In intermediate- and high-risk patients on beta-blockers, DSE can assist in identifying individuals who may benefit from cardiac revascularization prior to surgery.